Evidence map›Paper›PMID 39448861›Full record

ArticleBritish journal of cancer2024

Author Correction: CDK9 inhibition constrains multiple oncogenic transcriptional and epigenetic pathways in prostate cancer.

Razia Rahman, Muhammed H Rahaman, Adrienne R Hanson, Nicholas Choo, Jianling Xie, Scott L Townley, Raj Shrestha, Ramin Hassankhani, Saiful Islam, Susanne Ramm and 13 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Protein disulfide isomerases regulate androgen receptor stability and promote prostate cancer cell growth and survival.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Razia Rahman *Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia.
Muhammed H Rahaman *Drug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
Adrienne R HansonFlinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia.
Nicholas ChooBiomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.
Jianling XieFlinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia.ORCID http://orcid.org/0000-0002-0588-8016
Scott L TownleyFlinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia.
Raj ShresthaFlinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia.
Ramin HassankhaniDrug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
Saiful IslamDrug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
Susanne RammVictorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Kaylene J SimpsonVictorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Gail P RisbridgerBiomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.ORCID http://orcid.org/0000-0003-3089-4028
Giles BestFlinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia.
Margaret M CenteneraSouth Australian Health and Medical Research Institute, Adelaide, SA, Australia.
Steven P BalkBeth Israel Deaconess Medical Center, Boston, MA, USA.ORCID http://orcid.org/0000-0002-4546-7371
Ganessan KichenadasseFlinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia.ORCID http://orcid.org/0000-0001-9923-5149
Renea A TaylorThe Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.
Lisa M ButlerSouth Australian Health and Medical Research Institute, Adelaide, SA, Australia.ORCID http://orcid.org/0000-0003-2698-3220
Wayne D TilleyFaculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.ORCID http://orcid.org/0000-0003-1893-2626
Simon J ConnFlinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia.ORCID http://orcid.org/0000-0002-1376-4515
Mitchell G LawrenceBiomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia.
Shudong WangDrug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
Luke A SelthFlinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia. luke.selth@flinders.edu.au.ORCID http://orcid.org/0000-0002-4686-1418

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39448861
PMCPMC11555365

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.